Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma

Annals of Diagnostic Pathology

Volumn 17, Issue 5, 2013, Pages 425-429

  Chen, Pu Xiang ^a   Li, Qiao Yan ^a   Yang, Zhulin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Dehydrogenase1; Immunohistochemistry; Musashi 1; Ovarian cancer

Indexed keywords

AXL PROTEIN; CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL; PROSTASIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTADENOMA; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

DEHYDROGENASE1; IMMUNOHISTOCHEMISTRY; MUSASHI-1; OVARIAN CANCER;

ADENOCARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84884287079     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2013.01.005     Document Type: Article

References (16)

1. D. Van Simaeys, D. López-Colón, and K. Sefah Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX PLoS One 5 2010 e13770
2. E.B. Rankin, K.C. Fuh, and T.E. Taylor AXL is an essential factor and therapeutic target for metastatic ovarian cancer Cancer Res 70 2010 7570 7579
3. P. Hartge Designing early detection programs for ovarian cancer J Natl Cancer Inst 102 2010 3 4
4. L.J. Willmott, and J.P. Fruehauf Targeted therapy in ovarian cancer J Oncol 2010 2010 740472
5. F.P. Costa, E.L. Batista Jr., and A. Zelmanowicz Prostasin, a potential tumor marker in ovarian cancer - a pilot study Clinics (Sao Paulo) 64 2009 641 644
6. P. Yip, T.H. Chen, and P. Seshaiah Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers PLoS One 6 2011 e29533
7. V.A. Korshunov Axl-dependent signalling: a clinical update Clin Sci (Lond) 122 2012 361 368
8. S. Hafizi, and B. Dahlbäck Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases Cytokine Growth Factor Rev 17 2006 295 304
9. W.B. Ou, J.M. Corson, and D.L. Flynn AXL regulates mesothelioma proliferation and invasiveness Oncogene 30 2011 1643 1652
10. C. Gjerdrum, C. Tiron, and T. Høiby Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival Proc Natl Acad Sci USA 107 2010 1124 1129
11. K. Macleod, P. Mullen, and J. Sewell Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer Cancer Res 65 2005 6789 6800
12. W. Sun, J. Fujimoto, and T. Tamaya Coexpression of Gas6/Axl in human ovarian cancers Oncology 66 2004 450 457
13. J.X. Yu, L. Chao, and J. Chao Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland J Biol Chem 269 1994 18843 18848
14. L.M. Chen, M.L. Hatfield, and Y.Y. Fu Prostasin regulates iNOS and cyclin D1 expression by modulating protease-activated receptor-2 signaling in prostate epithelial cells Prostate 69 2009 1790 1801
15. C. Bergum, G. Zoratti, and J. Boerner Strong expression association between matriptase and its substrate prostasin in breast cancer J Cell Physiol 227 2012 1604 1609
16. C. López-Otín, and L.M. Matrisian Emerging roles of proteases in tumour suppression Nat Rev Cancer 7 2007 800 808